Literature DB >> 1992483

Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.

A Buchmann1, R Bauer-Hofmann, J Mahr, N R Drinkwater, A Luz, M Schwarz.   

Abstract

The frequency and pattern of mutations at codon 61 of the c-Ha-ras gene have been analyzed in 195 liver tumors and 132 precancerous liver lesions from various rodent strains with differing susceptibility to hepatocarcinogenesis. By using the polymerase chain reaction and allele-specific oligonucleotide hybridization, C----A transversions at the first base and A----T transversions or A----G transitions at the second base of c-Ha-ras codon 61 were detected in 20-60% of spontaneous or carcinogen-induced liver tumors of the C3H/He, CBA, CF1, and B6C3F1 mouse strains, which are highly susceptible to hepatocarcinogenesis. No such mutations, however, could be found in any of the 31 liver tumors of the insensitive C57BL/6J and BALB/c mouse strains or in any of the 35 liver tumors of the comparatively resistant Wistar rat. Further analyses of c-Ha-ras codon 12 mutations in liver tumors from the three insensitive rodent strains also failed to give any positive results. In early precancerous liver lesions, c-Ha-ras codon 61 mutations were found in 13-14% of lesions of the sensitive C3H/He and B6C3F1 mouse strains but not in any of the 34 lesions of the insensitive C57BL/6J mouse. Taken together, our results indicate a close correlation between the mutational activation of the c-Ha-ras gene in liver tumors of the different rodent strains and their susceptibility to hepatocarcinogenesis, whereby the mutations appear to provide a selective growth advantage, leading to a clonal expansion of the mutated liver cell population, only in livers of sensitive but not of insensitive strains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992483      PMCID: PMC50924          DOI: 10.1073/pnas.88.3.911

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.

Authors:  K Brown; A Buchmann; A Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.

Authors:  G McMahon; E F Davis; L J Huber; Y Kim; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 3.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

4.  Isolation and characterization of the 5' flanking region of the mouse c-Harvey-ras gene.

Authors:  K Brown; B Bailleul; M Ramsden; F Fee; R Krumlauf; A Balmain
Journal:  Mol Carcinog       Date:  1988       Impact factor: 4.784

5.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

6.  Sudden outbreak of a leukemia-like lesion in female CBA mice after repeated injections of 5-azacytidine.

Authors:  A Luz; A B Murray
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Tumour incidence and tumour spectrum of male Han:NMRI mice--short communication.

Authors:  J Kaspareit; F Deerberg
Journal:  Z Versuchstierkd       Date:  1987

8.  Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse.

Authors:  A Buchmann; J Mahr; R Bauer-Hofmann; M Schwarz
Journal:  Mol Carcinog       Date:  1989       Impact factor: 4.784

9.  Spontaneous tumors in NMRI mice from carcinogenicity studies.

Authors:  E Bomhard; U Mohr
Journal:  Exp Pathol       Date:  1989

10.  Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis.

Authors:  S Sinha; C Webber; C J Marshall; M A Knowles; A Proctor; N C Barrass; G E Neal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  31 in total

1.  Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Authors:  T M Poole; N R Drinkwater
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Defective apoptotic cell contractility provokes sterile inflammation, leading to liver damage and tumour suppression.

Authors:  Linda Julian; Gregory Naylor; Grant R Wickman; Nicola Rath; Giovanni Castino; David Stevenson; Sheila Bryson; June Munro; Lynn McGarry; Margaret Mullin; Alistair Rice; Armandodel Del Río Hernández; Michael F Olson
Journal:  Elife       Date:  2021-04-19       Impact factor: 8.140

3.  Molecular cloning of a rat chromosome putative recombinogenic sequence homologous to the hepatitis B virus encapsidation signal.

Authors:  H Aoki; K Kajino; Y Arakawa; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

4.  PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.

Authors:  Wei Qiu; Xinwei Wang; Brian Leibowitz; Wancai Yang; Lin Zhang; Jian Yu
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

5.  rAAV-mediated tumorigenesis: still unresolved after an AAV assault.

Authors:  Paul N Valdmanis; Leszek Lisowski; Mark A Kay
Journal:  Mol Ther       Date:  2012-11       Impact factor: 11.454

6.  Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma.

Authors:  Soumya C Iyer; Ashidha Gopal; Devaraj Halagowder
Journal:  Mol Cell Biochem       Date:  2015-06-24       Impact factor: 3.396

7.  Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Authors:  Zhuona Rong; Tingting Fan; Huiling Li; Juan Li; Kangwei Wang; Xinxin Wang; Jianyi Dong; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Mol Cell Proteomics       Date:  2017-05-16       Impact factor: 5.911

8.  Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors.

Authors:  Jennifer M Phillips; Jay I Goodman
Journal:  Toxicol Sci       Date:  2009-02-20       Impact factor: 4.849

9.  Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency.

Authors:  M J Berry; D Grieco; B A Taylor; A L Maia; J D Kieffer; W Beamer; E Glover; A Poland; P R Larsen
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 10.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.